196 related articles for article (PubMed ID: 19823586)
1. Rac inhibition reverses the phenotype of fibrotic fibroblasts.
Xu SW; Liu S; Eastwood M; Sonnylal S; Denton CP; Abraham DJ; Leask A
PLoS One; 2009 Oct; 4(10):e7438. PubMed ID: 19823586
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 promotes myofibroblast induction through the ETA receptor via a rac/phosphoinositide 3-kinase/Akt-dependent pathway and is essential for the enhanced contractile phenotype of fibrotic fibroblasts.
Shi-Wen X; Chen Y; Denton CP; Eastwood M; Renzoni EA; Bou-Gharios G; Pearson JD; Dashwood M; du Bois RM; Black CM; Leask A; Abraham DJ
Mol Biol Cell; 2004 Jun; 15(6):2707-19. PubMed ID: 15047866
[TBL] [Abstract][Full Text] [Related]
3. Systemic sclerosis endothelial cells recruit and activate dermal fibroblasts by induction of a connective tissue growth factor (CCN2)/transforming growth factor β-dependent mesenchymal-to-mesenchymal transition.
Serratì S; Chillà A; Laurenzana A; Margheri F; Giannoni E; Magnelli L; Chiarugi P; Dotor J; Feijoo E; Bazzichi L; Bombardieri S; Kahaleh B; Fibbi G; Del Rosso M
Arthritis Rheum; 2013 Jan; 65(1):258-69. PubMed ID: 22972461
[TBL] [Abstract][Full Text] [Related]
4. Antioxidants and NOX1/NOX4 inhibition blocks TGFβ1-induced CCN2 and α-SMA expression in dermal and gingival fibroblasts.
Murphy-Marshman H; Quensel K; Shi-Wen X; Barnfield R; Kelly J; Peidl A; Stratton RJ; Leask A
PLoS One; 2017; 12(10):e0186740. PubMed ID: 29049376
[TBL] [Abstract][Full Text] [Related]
5. COA-Cl prevented TGF-β1-induced CTGF expression by Akt dephosphorylation in normal human dermal fibroblasts, and it attenuated skin fibrosis in mice models of systemic sclerosis.
Nakai K; Karita S; Igarashi J; Tsukamoto I; Hirano K; Kubota Y
J Dermatol Sci; 2019 Apr; 94(1):205-212. PubMed ID: 30954335
[TBL] [Abstract][Full Text] [Related]
6. The fibrotic phenotype of systemic sclerosis fibroblasts varies with disease duration and severity of skin involvement: reconstitution of skin fibrosis development using a tissue engineering approach.
Corriveau MP; Boufaied I; Lessard J; Chabaud S; Senécal JL; Grodzicky T; Chartier S; Raymond Y; Moulin VJ
J Pathol; 2009 Mar; 217(4):534-42. PubMed ID: 19086038
[TBL] [Abstract][Full Text] [Related]
7. Role of endothelin-1 in the skin fibrosis of systemic sclerosis.
Jing J; Dou TT; Yang JQ; Chen XB; Cao HL; Min M; Cai SQ; Zheng M; Man XY
Eur Cytokine Netw; 2015; 26(1):10-4. PubMed ID: 25990837
[TBL] [Abstract][Full Text] [Related]
8. Attenuation of fibrosis with selective inhibition of c-Abl by siRNA in systemic sclerosis dermal fibroblasts.
Karimizadeh E; Motamed N; Mahmoudi M; Jafarinejad-Farsangi S; Jamshidi A; Faridani H; Gharibdoost F
Arch Dermatol Res; 2015 Mar; 307(2):135-42. PubMed ID: 25527259
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional profiling of the scleroderma fibroblast reveals a potential role for connective tissue growth factor (CTGF) in pathological fibrosis.
Leask A
Keio J Med; 2004 Jun; 53(2):74-7. PubMed ID: 15247510
[TBL] [Abstract][Full Text] [Related]
10. CCN5 overexpression inhibits profibrotic phenotypes via the PI3K/Akt signaling pathway in lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis and in an in vivo model of lung fibrosis.
Zhang L; Li Y; Liang C; Yang W
Int J Mol Med; 2014 Feb; 33(2):478-86. PubMed ID: 24276150
[TBL] [Abstract][Full Text] [Related]
11. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
[TBL] [Abstract][Full Text] [Related]
12. CXCL12 induces connective tissue growth factor expression in human lung fibroblasts through the Rac1/ERK, JNK, and AP-1 pathways.
Lin CH; Shih CH; Tseng CC; Yu CC; Tsai YJ; Bien MY; Chen BC
PLoS One; 2014; 9(8):e104746. PubMed ID: 25121739
[TBL] [Abstract][Full Text] [Related]
13. Scleroderma keratinocytes promote fibroblast activation independent of transforming growth factor beta.
McCoy SS; Reed TJ; Berthier CC; Tsou PS; Liu J; Gudjonsson JE; Khanna D; Kahlenberg JM
Rheumatology (Oxford); 2017 Nov; 56(11):1970-1981. PubMed ID: 28968684
[TBL] [Abstract][Full Text] [Related]
14. Connective tissue growth factor induces collagen I expression in human lung fibroblasts through the Rac1/MLK3/JNK/AP-1 pathway.
Lin CH; Yu MC; Tung WH; Chen TT; Yu CC; Weng CM; Tsai YJ; Bai KJ; Hong CY; Chien MH; Chen BC
Biochim Biophys Acta; 2013 Dec; 1833(12):2823-2833. PubMed ID: 23906792
[TBL] [Abstract][Full Text] [Related]
15. Chemokine receptor CCR2 expression by systemic sclerosis fibroblasts: evidence for autocrine regulation of myofibroblast differentiation.
Carulli MT; Ong VH; Ponticos M; Shiwen X; Abraham DJ; Black CM; Denton CP
Arthritis Rheum; 2005 Dec; 52(12):3772-82. PubMed ID: 16320328
[TBL] [Abstract][Full Text] [Related]
16. Semaphorin 4A enhances lung fibrosis through activation of Akt via PlexinD1 receptor.
Peng HY; Gao W; Chong FR; Liu HY; Zhang JI
J Biosci; 2015 Dec; 40(5):855-62. PubMed ID: 26648031
[TBL] [Abstract][Full Text] [Related]
17. 5-HT
Chaturvedi S; Misra DP; Prasad N; Rastogi K; Singh H; Rai MK; Agarwal V
Int J Rheum Dis; 2018 Dec; 21(12):2128-2138. PubMed ID: 30207074
[TBL] [Abstract][Full Text] [Related]
18. Dabigatran, a direct thrombin inhibitor, demonstrates antifibrotic effects on lung fibroblasts.
Bogatkevich GS; Ludwicka-Bradley A; Silver RM
Arthritis Rheum; 2009 Nov; 60(11):3455-64. PubMed ID: 19877031
[TBL] [Abstract][Full Text] [Related]
19. CTGF and SMADs, maintenance of scleroderma phenotype is independent of SMAD signaling.
Holmes A; Abraham DJ; Sa S; Shiwen X; Black CM; Leask A
J Biol Chem; 2001 Apr; 276(14):10594-601. PubMed ID: 11152469
[TBL] [Abstract][Full Text] [Related]
20. Fibrosis caused by loss of PTEN expression in mouse fibroblasts is crucially dependent on CCN2.
Liu S; Parapuram SK; Leask A
Arthritis Rheum; 2013 Nov; 65(11):2940-4. PubMed ID: 23983074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
